drug protocol number

ARGX-113-2306

drug sponsor

Argenx BV / IQVIA

drug study

Efgartigimod

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh) , King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase